Pathos AI, ( a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, announced the first patient has been dosed in the Company’s Phase 1b/2a ...

Future Oncol. 2010;6(5):665-679. Three Phase I studies by O'Donnell and colleagues have reported the pharmacodynamic activity of abiraterone acetate, which was originally developed as an oral ...

A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Abiraterone acetate (CB7630), a pregnenolone analog, is an orally administered small molecule that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, CYP17, and blocks the ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Trials have shown abiraterone can stop prostate cancer from spreading and it can extend the lives of those with the disease.

The charity’s much-loved events, which raise funds for life-saving research, are returning to Wigan. Anyone who joins between ...

People are being invited to step into spring by signing up for Cancer Research UK’s Race for Life in Doncaster.

医学Medicine2025年3月7日，复旦大学附属肿瘤医院叶定伟/朱耀/黄胜林教授团队在Cell Press细胞出版社旗下期刊Cell Reports Medicine发表了一篇论文，题为“Neoadjuvant Fuzuloparib ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...